Stealthy biotech buys up patent portfolios in string of recent deals
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement
Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech
President Biden and other leaders are coming under pressure to agree a suspension of IP rights, but a key point has been missed
20 April 2021
Top voices from industry and private practice reckon with the strengths and weaknesses of country’s IP environment
15 April 2021
Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible
13 April 2021
Hub-and-spokes life sciences companies are providing new opportunities for IP monetisation
08 April 2021
Sigma-Aldrich’s patent loss could be a sign of things to come for several ongoing opposition proceedings
01 April 2021
Semiconductor Energy Lab settles US case against BOE and promptly targets China Star Optoelectronics, another major panel maker
29 March 2021
25 March 2021
25 March 2021
25 March 2021
Get unlimited access to all IAM content